Prospective, randomized, controlled, and open study in primarily inoperable, stage III non-small cell lung cancer (NSCLC) patients given sequential radiochemotherapy with or without epoetin alfa-Reference-Cited by-同舟云学术

Prospective, randomized, controlled, and open study in primarily inoperable, stage III non-small cell lung cancer (NSCLC) patients given sequential radiochemotherapy with or without epoetin alfa

Published:2014-07 Issue:1 Volume:112 Page:23-29
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Debus Jürgen,Drings Peter,Baurecht Werner,Angermund Ralf^ORCID

Funder

Ortho Biotech Germany

Division of Janssen-Cilag GmbH

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference46 articles.

1. A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer;Kim;Am J Clin Oncol,2002

2. O’Rourke N, Roque IFM, Farre Bernado N, et al. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochr Datab Syst Rev 2010: CD002140.

3. Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity;Socinski;Ann Oncol,2004

4. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Auperin;J Clin Oncol,2010

5. Rowell NP, O’Rourke NP. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochr Datab Syst Rev 2004:CD002140.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of erythropoiesis‑stimulating agents on lung cancer patients: a meta‑analysis;Clinical and Experimental Medicine;2024-07-05

2. Prognostic significance of lab data and performance comparison by validating survival prediction models for patients with spinal metastases after radiotherapy;Radiotherapy and Oncology;2022-10

3. Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2022-06-20

4. Supportive Treatments for Patients with Cancer;Deutsches Ärzteblatt international;2017-07-10

5. Emerging targets for radioprotection and radiosensitization in radiotherapy;Tumor Biology;2016-06-19